Remove Fragment Screening Remove Pharmacokinetics Remove Research
article thumbnail

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

PerkinElmer

Researchers are now studying the potential of protease inhibitors for the treatment of SARS-CoV-2. 2 In the present study, the researchers report that PF-07321332 demonstrated potent inhibition in FRET M pro assays representing M pro from all coronavirus types known to infect humans.